Fatigue and @entity146 morbidity among XXXX .

@entity1 @entity308 @entity146 @entity5 @entity1295 @entity458 @entity148 @entity978
Fatigue is prevalent among @entity5 @entity1 , including @entity978 ( @entity978 ). Fatigue is poorly understood, and the clinical management is consequently difficult. This cross-sectional study examined how @entity1295 related to @entity146 morbidity among 457 @entity978 (aged 19-74 years, 56% males) treated during the period 1971-1991. The subjects were mailed a questionnaire including the Fatigue Questionnaire, the Hospital Anxiety and @entity308 Scale, and measures of previous @entity146 problems. Fatigue correlated moderately with @entity148 and @entity308 (r = 0.44 and 0.41 respectively). Twenty-six percent of the @entity978 had substantial @entity1295 for 6 months or longer (=cases). They had higher levels of @entity148 (mean 7.3, 95% CI 6.4-8.1) and @entity308 (mean 4.5, 95% CI 3.8-5.2) than the non-cases ( @entity148 : mean 4.3, 95% CI 3.9-4.7; @entity308 : mean 2.1, 95% CI 1.8-2.5). Past @entity146 problems were not reported more commonly among the @entity1295 cases than among the non-cases. A multiple logistic regression analysis identified age (OR 1.04, 95% CI 1.02-1.06), @entity148 (OR 1.2, 95% CI 1.2-1.3), and no self-reported @entity146 symptoms during treatment (OR 2.3, 95% CI 1.3-4.2) as predictors of @entity1295 caseness. One-half of the @entity1295 cases among @entity978 have @entity458 that might respond to treatment. Chronic @entity1295 among @entity978 is not predicted by previous @entity146 problems.
